USANA Health Sciences Q1 revenue flat, profit drops

USANA Health Sciences

05/05/2026 21:33

Overview

Nutritional supplements maker's fiscal Q1 revenue was flat yr/yr at $250 mln

Adjusted EPS for fiscal Q1 fell 16% yr/yr to $0.61

Company reaffirmed its fiscal 2026 guidance

Outlook

USANA reiterates fiscal 2026 consolidated net sales guidance of $925 mln to $1.0 bln

Company expects fiscal 2026 net earnings of $20 mln to $27 mln

USANA projects fiscal 2026 adjusted diluted EPS of $1.95 to $2.29

Result Drivers

CHINA CUSTOMER GROWTH - Sequential improvement in Core Nutritional segment driven by growth in total active customers in China

RETAILER ORDERS - Rise Wellness generated triple-digit growth as Protein Pop hit Costco shelves nationwide

DECLINING HIYA SUBSCRIBERS - Hiya established the operational foundation for a meaningfully stronger second half of the year, but active monthly subscribers fell 17% yr/yr

Company press release: ID:nBw6BXHVja

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Beat
$250 mln
$240.99 mln (1 Analyst)
Q1 EPS
$0.41
Q1 Net Earnings
$7.50 mln


Analyst Coverage

Wall Street's median 12-month price target for USANA Health Sciences Inc is $39.00, about 110.1% above its May 4 closing price of $18.56

The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 11 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)